Top Globe News – Lifestyle
Author:
Artios Pharma
Artios Announces Clinical Trial Collaboration with GSK to Evaluate Alnodesertib in Combination with Risvutatug Rezetecan, a B7-H3-Targeted ADC in Gastrointestinal Tumors
May 12, 2026
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
May 4, 2026